KR20240041068A - Cosmetic Composition With Enhancing Skin Absorption and Without Skin Irritation - Google Patents
Cosmetic Composition With Enhancing Skin Absorption and Without Skin Irritation Download PDFInfo
- Publication number
- KR20240041068A KR20240041068A KR1020220120143A KR20220120143A KR20240041068A KR 20240041068 A KR20240041068 A KR 20240041068A KR 1020220120143 A KR1020220120143 A KR 1020220120143A KR 20220120143 A KR20220120143 A KR 20220120143A KR 20240041068 A KR20240041068 A KR 20240041068A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- skin
- butanediol
- bis
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 239000002537 cosmetic Substances 0.000 title claims abstract description 36
- 231100000274 skin absorption Toxicity 0.000 title claims abstract description 30
- 230000037384 skin absorption Effects 0.000 title claims abstract description 30
- 206010040880 Skin irritation Diseases 0.000 title abstract description 15
- 230000036556 skin irritation Effects 0.000 title abstract description 15
- 231100000475 skin irritation Toxicity 0.000 title abstract description 15
- 230000002708 enhancing effect Effects 0.000 title 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 claims abstract description 19
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000004480 active ingredient Substances 0.000 claims abstract description 18
- JNFDQAYPZCYWLD-UHFFFAOYSA-N bis[2-(2-ethoxyethoxy)ethyl] cyclohexane-1,4-dicarboxylate Chemical compound CCOCCOCCOC(=O)C1CCC(C(=O)OCCOCCOCC)CC1 JNFDQAYPZCYWLD-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000004615 ingredient Substances 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- -1 pack Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 230000002087 whitening effect Effects 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 abstract description 7
- 241001674048 Phthiraptera Species 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 34
- 210000003491 skin Anatomy 0.000 description 18
- 238000011156 evaluation Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 235000005152 nicotinamide Nutrition 0.000 description 4
- 239000011570 nicotinamide Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 231100000245 skin permeability Toxicity 0.000 description 3
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000000823 artificial membrane Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000344 non-irritating Toxicity 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 150000004040 pyrrolidinones Chemical class 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
본 발명은 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트 및 에톡시다이글라이콜을 포함하여 유효성분의 피부 흡수율 증진에 효과가 있고 피부 자극이 없는 화장료 조성물을 제공한다. 특히, 본 발명은 상기 3가지 원료를 최적의 비율로 혼합 사용하여 유효성분의 피부 흡수율을 증진시키고 피부 자극을 최소화한 것을 특징으로 한다.The present invention is effective in improving the skin absorption rate of active ingredients, including 2,3-butanediol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, and ethoxydiglycol, and reduces skin irritation. Provided is a cosmetic composition without lice. In particular, the present invention is characterized by improving the skin absorption rate of the active ingredient and minimizing skin irritation by mixing the above three raw materials in an optimal ratio.
Description
본 발명은 유효성분의 피부 흡수율 증진 효과가 있고 피부 자극이 없는 화장료 조성물에 관한 것으로서, 구체적으로는 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트 및 에톡시다이글라이콜을 포함하여 유효성분의 피부 흡수율 증진에 효과가 있고 피부 자극이 없는 화장료 조성물을 제공한다.The present invention relates to a cosmetic composition that has the effect of improving the skin absorption rate of active ingredients and does not cause skin irritation, specifically, 2,3-butanediol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate and ethoxydiglycol, and provides a cosmetic composition that is effective in increasing the skin absorption rate of the active ingredient and does not cause skin irritation.
피부는 크게 각질층, 표피층, 진피층의 세 부분으로 구성되어 있는데, 화장품 같은 피부 외용제 조성물에 함유되어 있는 활성성분들은 피부흡수에 있어서 최외각에 존재하는 피부 장벽을 통과하여 얼마나 빠르고 지속적으로 흡수되는지에 따라 그 효과가 결정된다. 아무리 효과가 뛰어난 활성성분이라도 피부 내부로 흡수가 되지 않는다면 그 효과를 기대할 수 없다. The skin is largely composed of three parts: the stratum corneum, the epidermis, and the dermis. The active ingredients contained in external skin preparation compositions such as cosmetics are absorbed through the outermost skin barrier, depending on how quickly and continuously they are absorbed. The effect is determined. No matter how effective an active ingredient is, if it is not absorbed into the skin, its effectiveness cannot be expected.
또한, 피부의 각질층은 케라틴 단백질을 주성분으로 하는 각질세포와 각질 세포간을 구성하는 지질층으로 이루어져 있으므로, 지용성 활성성분은 원활하게 피부에 흡수되지만, 수용성 및 분자량이 큰 활성성분은 피부를 투과하기 어렵다. 따라서, 대부분이 수용성인 화장품 등의 피부 외용제에 함유되어 있는 활성성분은 피부 내부로 흡수가 용이하지 않다.In addition, the stratum corneum of the skin is composed of keratinocytes containing keratin protein as a main component and a lipid layer that forms between keratinocytes, so fat-soluble active ingredients are smoothly absorbed into the skin, but water-soluble and high molecular weight active ingredients have difficulty penetrating the skin. . Therefore, the active ingredients contained in external skin preparations such as cosmetics, which are mostly water-soluble, are not easily absorbed into the skin.
피부는 본래 외부로부터의 이물질의 침입이나 체내로부터 수분의 증발을 막는 베리어로써 작용하며, 일반 생체막에 비해 물질의 투과성이 적어 피부흡수제제를 설계함에 있어서 피부투과성을 어떤 방식으로 개선하는지가 중요한 과제가 된다. 예를 들면 활성성분의 열역학적 활동도가 커지는 기제를 선택하거나 활성성분의 수용성 및 지용성을 높이기 위해서 프로드럭화 하거나 포접화합물을 이용하여 복합체를 형성하거나 또는 이온토포레시스를 이용하는 방법 등이 시도되어 왔으나, 특정 물질만 가능한 점, 비용이 많이 드는 점, 실질적으로 적용이 제한적인 부분 등이 존재한다. The skin originally acts as a barrier to prevent the intrusion of foreign substances from the outside or the evaporation of moisture from the body, and has less permeability to substances than general biological membranes, so how to improve skin permeability is an important task when designing skin absorption products. do. For example, attempts have been made to select a mechanism that increases the thermodynamic activity of the active ingredient, to increase the water-solubility and fat-solubility of the active ingredient, by making it a prodrug, forming a complex using an inclusion compound, or using iontophoresis. , there are points where only certain materials are available, points where the cost is high, and areas where practical application is limited.
이를 극복하기 위해 가장 일반적인 방법으로 사용되는 것은 피부흡수촉진제를 이용하는 것이다. 피부흡수촉진제로는 아존 및 유사화합물 계열 지방산 및 알코올 에스테르, 알킬메틸술폭시드 및 피롤리돈 화합물 등이 주로 사용되어 왔는데, 이들을 사용할 때 피부투과도를 만족할만한 수준으로 증가시키면서 피부자극 등과 같은 부작용의 발생의 위험을 최소화시킬 수 있는 피부흡수촉진제 선택에 대한 요구는 여전히 존재한다.The most common way to overcome this is to use skin absorption enhancers. Azone and similar compound fatty acid and alcohol esters, alkylmethyl sulfoxide, and pyrrolidone compounds have been mainly used as skin absorption enhancers. When these are used, side effects such as skin irritation occur while increasing skin permeability to a satisfactory level. There is still a need to select a skin absorption enhancer that can minimize the risk.
유효성분의 피부 흡수 촉진과 관련하여, 한국공개특허 제2019-0051880호는 해면 골편을 포함하여, 조성물의 경피 흡수를 촉진시키고 지속력을 향상시키고, 피부 자극이 없는 화장료 조성물을 개시한다. In relation to promoting skin absorption of active ingredients, Korean Patent Publication No. 2019-0051880 discloses a cosmetic composition that contains spongy bone fragments, promotes transdermal absorption of the composition, improves durability, and is non-irritating to the skin.
또한, 한국등록특허 제10-2035260호는 비타민 C를 프로판다이올, 프로필렌카보네이트, 에톡시다이글라이콜 등을 포함하는 혼합용매에 용해시켜, 피부 흡수율을 증가시킨 화장료 조성물을 개시한다.In addition, Korean Patent No. 10-2035260 discloses a cosmetic composition in which vitamin C is dissolved in a mixed solvent containing propanediol, propylene carbonate, ethoxydiglycol, etc., thereby increasing skin absorption rate.
본 발명은 알코올 에스테르, 양쪽성 화합물, 폴리올 및 정제수를 포함하여 피부 흡수율 증진에 효과가 있는 화장료 조성물을 제공하는 것을 목적으로 한다.The purpose of the present invention is to provide a cosmetic composition effective in improving skin absorption rate, including alcohol ester, amphoteric compound, polyol, and purified water.
상기한 과제는, 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트, 에톡시다이글라이콜 및 정제수를 포함하는 피부 흡수율 증진 효과를 갖는 화장료 조성물에 의해 달성된다.The above-mentioned problem is to provide a cosmetic composition having an effect of improving skin absorption rate containing 2,3-butanediol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, ethoxydiglycol, and purified water. is achieved by
바람직하게는, 상기 화장료 조성물은 화장료 조성물 총 중량 대비 상기 2,3-부탄다이올을 1.00 내지 20.00 중량%, 상기 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트를 1.00 내지 5.00 중량%, 상기 에톡시다이글라이콜을 1.00 내지 7.50 중량%로 포함할 수 있다.Preferably, the cosmetic composition contains 1.00 to 20.00% by weight of 2,3-butanediol and 1.00 to 5.00% by weight of bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, based on the total weight of the cosmetic composition. Weight percent, the ethoxy diglycol may be included in an amount of 1.00 to 7.50 weight percent.
또한 바람직하게는, 상기 화장료 조성물은 유효성분으로서 미백성분, 보습성분, 주름개선성분을 포함할 수 있다.Also preferably, the cosmetic composition may include a whitening ingredient, a moisturizing ingredient, and a wrinkle-improving ingredient as active ingredients.
또한 바람직하게는, 상기 화장료 조성물은 유연화장수, 영양화장수, 마사지크림, 영양크림, 팩, 젤, 에센스, 메이크업 베이스, 파운데이션, 로션, 연고, 겔, 크림, 패취 및 분무제로 이루어진 군에서 선택된 제형일 수 있다.Also preferably, the cosmetic composition is a formulation selected from the group consisting of softening lotion, nourishing lotion, massage cream, nourishing cream, pack, gel, essence, makeup base, foundation, lotion, ointment, gel, cream, patch, and spray. You can.
본 발명에 따른 화장료 조성물은 에톡시다이글라이콜, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트, 2,3-부탄다이올을 포함하여 유효성분의 피부 흡수율 증진에 효과가 있으며, 피부 자극이 거의 없다.The cosmetic composition according to the present invention is effective in improving the skin absorption rate of active ingredients, including ethoxydiglycol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, and 2,3-butanediol. There is almost no skin irritation.
본 발명에서 사용되는 모든 기술용어는, 달리 정의되지 않는 이상, 하기의 정의를 가지며 본 발명의 관련 분야에서 통상의 당업자가 일반적으로 이해하는 바와 같은 의미에 부합된다. 또한 본 명세서에는 바람직한 방법이나 시료가 기재되나, 이와 유사하거나 동등한 것들도 본 발명의 범주에 포함된다.All technical terms used in the present invention, unless otherwise defined, have the following definitions and correspond to the meaning as generally understood by a person skilled in the art in the relevant field of the present invention. In addition, preferred methods and samples are described in this specification, but similar or equivalent methods are also included in the scope of the present invention.
용어 "약"이라는 것은 참조 양, 수준, 값, 수, 빈도, 퍼센트, 치수, 크기, 양, 중량 또는 길이에 대해 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 4, 3, 2 또는 1% 정도로 변하는 양, 수준, 값, 수, 빈도, 퍼센트, 치수, 크기, 양, 중량 또는 길이를 의미한다.The term “about” means 30, 25, 20, 15, 10, 9, 8, 7, 6, 5, 9, 8, 7, 6, 5, or means a quantity, level, value, number, frequency, percentage, dimension, size, volume, weight or length that varies by 4, 3, 2 or 1%.
본 명세서를 통해, 문맥에서 달리 필요하지 않으면, "포함하다" 및 "포함하는"이란 말은 제시된 단계 또는 구성요소, 또는 단계 또는 구성요소들의 군을 포함하나, 임의의 다른 단계 또는 구성요소, 또는 단계 또는 구성요소들의 군이 배제되지는 않음을 내포하는 것으로 이해하여야 한다.Throughout this specification, unless the context otherwise requires, the words "comprise" and "comprising" include a given step or component, or group of steps or components, but any other step or component, or It should be understood that this implies that no step or group of components is excluded.
본 발명은 알코올 에스테르, 양쪽성 화합물, 폴리올 및 정제수를 포함하여 유효성분의 피부흡수율을 증진시키고, 자극이 없는 화장료 조성물에 관한 것이다.The present invention relates to a non-irritating cosmetic composition that improves skin absorption of active ingredients and contains alcohol esters, amphoteric compounds, polyols, and purified water.
일반적으로 프로드럭화 하거나 포접화합물을 이용하여 복합체를 형성하거나 또는 이온토포레시스를 이용하는 방법 등은 특정 물질만 가능한 점, 비용이 많이 드는 점, 실질적으로 적용이 제한적인 부분 등의 단점이 존재하며, 피부흡수촉진제로서는 아존 및 유사화합물 계열 지방산 및 알코올 에스테르, 알킬메틸술폭시드 및 피롤리돈 화합물 등을 사용할 때 피부투과도를 만족할만한 수준으로 증가시키면 피부자극 등과 같은 부작용의 발생의 위험이 있다. In general, methods such as prodrugation, forming complexes using inclusion compounds, or using iontophoresis have disadvantages such as being available only for specific materials, being expensive, and having limited practical application. , When using azone and similar compounds such as fatty acids and alcohol esters, alkylmethyl sulfoxide, and pyrrolidone compounds as skin absorption enhancers, there is a risk of side effects such as skin irritation if the skin permeability is increased to a satisfactory level.
본 발명은 에톡시다이글라이콜, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트 및 2,3-부탄다이올을 포함하는 화장료 조성물을 제공하여, 유효성분의 피부흡수를 촉진시키며 피부자극 등과 같은 부작용 발생이 거의 없는 화장료 조성물에 관한 것이다.The present invention provides a cosmetic composition containing ethoxydiglycol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, and 2,3-butanediol, which improves skin absorption of the active ingredient. It relates to a cosmetic composition that stimulates the skin and has little side effects such as skin irritation.
바람직하게는, 상기 화장료 조성물은 화장료 조성물 총 중량 대비 2,3-부탄다이올을 1.00 내지 20.00 중량%, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트를 1.00 내지 5.00 중량%, 상기 에톡시다이글라이콜을 1.00 내지 7.50 중량%로 포함할 수 있다. Preferably, the cosmetic composition contains 1.00 to 20.00% by weight of 2,3-butanediol and 1.00 to 5.00% by weight of bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate based on the total weight of the cosmetic composition. , it may contain 1.00 to 7.50% by weight of ethoxydiglycol.
또한, 상기 화장료 조성물은 유효성분으로서, 미백성분, 보습성분, 주름개선성분을 포함할 수 있다. 일 실시형태에 따르면, 상기 미백성분으로는 나이아신아마이드, 알부틴, 닥나무추출물이 있고, 보습성분으로는 트레할로오스, 베타인, 자일리톨이 있으며, 주름개선성분은 아데노신이 있으나, 이들 종류는 특별히 제한되지 않는다. Additionally, the cosmetic composition may include whitening ingredients, moisturizing ingredients, and wrinkle-improving ingredients as active ingredients. According to one embodiment, the whitening ingredients include niacinamide, arbutin, and mulberry extract, the moisturizing ingredients include trehalose, betaine, and xylitol, and the wrinkle-improving ingredient includes adenosine, but these types are particularly limited. It doesn't work.
또한, 상기 화장료 조성물은 유연화장수, 영양화장수, 마사지크림, 영양크림, 팩, 젤, 에센스, 메이크업 베이스, 파운데이션, 로션, 연고, 겔, 크림, 패취 및 분무제로 이루어진 군에서 선택된 제형을 가질 수 있다.In addition, the cosmetic composition may have a formulation selected from the group consisting of softening lotion, nourishing lotion, massage cream, nourishing cream, pack, gel, essence, makeup base, foundation, lotion, ointment, gel, cream, patch, and spray. .
아래에서 실시예를 들어서 본 발명을 상세하게 설명하지만, 이들 실시예에 의해 본 발명의 권리범위가 제한되는 것은 아니다.The present invention will be described in detail below by giving examples, but the scope of the present invention is not limited by these examples.
실시예 및 비교예 : 피부 흡수율 증진에 효과가 있는 화장료 조성물의 제조Examples and Comparative Examples: Preparation of a cosmetic composition effective in improving skin absorption rate
하기 표 1에 기재된 각 성분과 함량에 따라 각 원료를 비이커에 계량한 후 20~80℃의 온도에서 호모 믹서(Homo mixer)를 이용하여 A상(수상 부)을 3000rpm으로 5분간 균일하게 혼합하였다. 혼합 후 B상(유상 부)를 같은 온도에서 투입 후 3000rpm으로 10분간 균일하게 혼합하였다. 그 다음 C상(첨가제 부)을 넣어 3000rpm으로 5분간 균일하게 혼합한 후 기포를 제거하여 화장료 조성물을 제조하였다.Each raw material was weighed in a beaker according to the components and contents listed in Table 1 below, and then the A phase (aqueous phase) was uniformly mixed at 3000 rpm for 5 minutes using a homo mixer at a temperature of 20 to 80 ° C. . After mixing, phase B (oil phase) was added at the same temperature and mixed uniformly at 3000 rpm for 10 minutes. Next, phase C (additive part) was added and mixed uniformly at 3000 rpm for 5 minutes, and air bubbles were removed to prepare a cosmetic composition.
비교예 1 내지 비교예 3은 피부 흡수율 증진에 효과가 있는 2,3-부탄다이올, 에톡시다이글라이콜, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트를 단독으로 사용하였고, 비교예 4 및 실시예 1 내지 실시예 3은 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트, 에톡시다이글라이콜의 3 가지 원료를 혼합하여 제조하였다.Comparative Examples 1 to 3 are 2,3-butanediol, ethoxydiglycol, and bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, which are effective in improving skin absorption rate, alone. Comparative Example 4 and Examples 1 to 3 were three types of 2,3-butanediol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, and ethoxydiglycol. It was manufactured by mixing raw materials.
실험예 1: 제형 안정도 평가Experimental Example 1: Evaluation of formulation stability
피부 흡수율 증진에 효과가 있는 화장료 조성물의 안정도를 확인하기 위하여 상기 실시예 와 비교예 의 화장료 조성물의 안정도를 평가하였다. 구체적으로는, 본 발명의 실시예 와 비교예를 4주간 냉장, 상온, 45℃, 50℃, Cycle Test(C/T),에서 항온조 보관하는 방법을 통해 안정도를 확인하였다. 그 결과를 표 2에 나타내었다.In order to confirm the stability of the cosmetic composition effective in improving skin absorption rate, the stability of the cosmetic composition of the above Examples and Comparative Examples was evaluated. Specifically, the stability of the Examples and Comparative Examples of the present invention was confirmed by storing them in a thermostat under refrigeration, room temperature, 45°C, 50°C, Cycle Test (C/T) for 4 weeks. The results are shown in Table 2.
- ○: 양호, △: 처음과 차이 있음, ×: 성상 변화(분리, 현탁, 경도 변화, 사용감) - ○: Good, △: Difference from the first time, ×: Change in properties (separation, suspension, change in hardness, feeling of use)
표 2를 보면, 비교예 3 내지 비교예 4를 제외한 모든 제형에서 1달간 모든 온도 조건에서 안정적이었다.Looking at Table 2, all formulations except Comparative Examples 3 to 4 were stable under all temperature conditions for one month.
실험예 2: 사용성 평가Experimental Example 2: Usability Evaluation
피부 흡수율 증진에 효과가 있는 화장료 조성물의 사용성을 확인하기 위하여, 상기 실시예 1 내지 3 및 비교예 1 내지 4의 사용감을 평가하기 위하여 성인 여성 30명을 대상으로, 실시예 1 내지 3 및 비교예 1 내지 4를 각 군에 적절히 조절하여 얼굴 양쪽 부위에 사용하게 한 후, 하기 평가 기준에 따라 바를 때 느끼는 발림성, 영양감, 밀착성의 사용감을 평가하여 그 결과를 하기 표 3에 나타내었다. 상기 기준 중 발림성은 피부에 펴 발리는 느낌으로 피부에 부드럽게 발리는 성질로 뻑뻑함, 끈적임 없이 발리는 것을 포함한다. 영양감은 피부에 도포 시 피부에 영양과 보습을 부여하는 느낌을 말한다. 밀착성은 피부에 도포 시 조성물이 피부 표면에 얇게 발려 피부에 달라붙는 느낌을 말한다. 이와 같은 세 가지 기준은 화장료로의 사용 가치를 높여준다. 평가기준은 다음과 같다:In order to confirm the usability of a cosmetic composition that is effective in improving skin absorption rate, 30 adult women were tested to evaluate the feeling of use of Examples 1 to 3 and Comparative Examples 1 to 4. After 1 to 4 were appropriately adjusted to each group and used on both sides of the face, the feeling of spreadability, nutrition, and adhesion felt when applied was evaluated according to the evaluation criteria below, and the results are shown in Table 3 below. Among the above criteria, spreadability includes the ability to spread smoothly on the skin without feeling thick or sticky. Nourishment refers to the feeling of providing nutrition and moisture to the skin when applied to the skin. Adhesion refers to the feeling that the composition is spread thinly on the skin surface and sticks to the skin when applied to the skin. These three standards increase the value of use as a cosmetic. The evaluation criteria are as follows:
- 24명 이상의 여성이 우수하다고 판정: ◎ (매우양호)- More than 24 women judged it excellent: ◎ (very good)
- 8-23명의 여성이 우수하다고 판정: O (양호)- 8-23 women judged excellent: O (good)
- 10-17명의 여성이 우수하다고 판정: △ (보통)- 10-17 women judged as excellent: △ (average)
- 10명 이하의 여성이 우수하다고 판정: X (나쁨)- Less than 10 women judged as excellent: X (poor)
만족도Overall
satisfaction
표 3에서 확인된 바와 같이, 실시예 1 내지 3 의 발림성, 영양감, 밀착성 및 전반적인 만족도가 비교예 1 내지 4보다 우수한 것으로 나타났다. 특히, 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트, 에톡시다이글라이콜 3가지 원료를 혼합한 제형 중 실시예 1 내지 실시예 3의 사용감이 가장 좋은 것으로 나타났다. 에톡시다이글라이콜을 단독으로 사용한 비교예 1은 발림성은 우수하나, 영양감 및 밀착감이 매우 떨어졌다. 또한 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트를 각각 단독으로 함유한 비교예 2 와 비교예 3은 발림성은 우수하나 영양감 및 밀착성이 떨어져 전반적인 만족도가 낮았으며, 2,3-부탄다이올, 에톡시다이글라이콜, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트 3가지 원료를 과량 사용한 비교예 4는 발림성 및 밀착성이 전반적인 만족도가 낮았다.As confirmed in Table 3, the spreadability, nutritiousness, adhesion, and overall satisfaction of Examples 1 to 3 were found to be superior to those of Comparative Examples 1 to 4. In particular, among the formulations mixing three raw materials, 2,3-butanediol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, and ethoxydiglycol, Examples 1 to 3 It was found to have the best feeling of use. Comparative Example 1, in which ethoxy diglycol was used alone, had excellent spreadability, but had very poor nutritional and adhesion properties. In addition, Comparative Examples 2 and 3, which contained 2,3-butanediol and bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate respectively, had excellent spreadability, but poor nutrition and adhesion, resulting in poor overall Satisfaction was low, and Comparative Example 4, which used an excessive amount of the three raw materials 2,3-butanediol, ethoxydiglycol, and bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, had poor spreadability and adhesion. This overall satisfaction was low.
실험예 3: 피부 흡수 효과 확인Experimental Example 3: Confirmation of skin absorption effect
상기 실시예 1 내지 3 및 비교예 1 내지 4에 대하여 인 비트로(in vitro) 조건에서 수용성 활성물질인 나이아신아마이드의 피부 흡수 효과를 평가하기 위하여 프란츠셀을 사용한 실험을 하였다.For Examples 1 to 3 and Comparative Examples 1 to 4, an experiment was conducted using Franz Cell to evaluate the skin absorption effect of niacinamide, a water-soluble active substance, under in vitro conditions.
구체적으로, 오픈된 형태인 유리 초자 내부에 Merck사에서 제조하는 인공막(Strat-M)을 올려두고, 그 위에 실시예 1 내지 3 및 비교예 1 내지 4 을 각각 적량 도포한 후, 충분히 흡수시켰다. 수용체(acceptor) 부분에는 PBS 13mL을 채웠고, 32℃에서 투과 실험을 진행하였다. 1, 2, 4, 8시간 경과 후, PBS 용매를 이용하여 인공막을 투과한 수용체 부분 을 추출한 후, HPLC 분석을 통해 나이아신아마이드 농도를 측정하였다. HPLC 분석 조건은 하기 표 4와 같다.Specifically, an artificial membrane (Strat-M) manufactured by Merck was placed inside an open glass glass, and Examples 1 to 3 and Comparative Examples 1 to 4 were applied in appropriate amounts thereon and then sufficiently absorbed. The receptor portion was filled with 13 mL of PBS, and a permeation experiment was performed at 32°C. After 1, 2, 4, and 8 hours, the receptor portion that penetrated the artificial membrane was extracted using a PBS solvent, and the niacinamide concentration was measured through HPLC analysis. HPLC analysis conditions are shown in Table 4 below.
도 1은 실시예 1 내지 3 및 비교예 1 내지 4에 대한 인 비트로(in vitro) 피부 흡수 효과 평가 결과이다. 구체적으로 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트, 에톡시다이글라이콜을 각각 1종만 포함하는 비교예 1 내지 3 보다, 상기 3종을 모두 포함하는 실시예 1 내지 3에서 인 비트로 조건에서 우수한 피부 흡수를 보여주었다. Figure 1 shows the in vitro skin absorption effect evaluation results for Examples 1 to 3 and Comparative Examples 1 to 4. Specifically, rather than Comparative Examples 1 to 3, which contain only one type each of 2,3-butanediol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, and ethoxydiglycol, the above three types Examples 1 to 3 including all showed excellent skin absorption under in vitro conditions.
특히 실시예 1 내지 3에서 우수한 피부 흡수를 보여주었다. 또한, 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트,에톡시다이글라이콜을 과량으로 포함하여 제형이 불안정한 비교예 4는, 상기 3가지 원료를 적은 함량으로 적정한 비율로 포함한 실시예 1 내지 3보다 낮은 피부 흡수를 보였다. 이는 적절한 2,3-부탄다이올 및 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트를 포함하여 제형이 안정해야 피부 흡수율이 좋다는 것을 보여준다.In particular, Examples 1 to 3 showed excellent skin absorption. In addition, Comparative Example 4, which has an unstable formulation because it contains an excessive amount of 2,3-butanediol, bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate, and ethoxydiglycol, contains the above three It showed lower skin absorption than Examples 1 to 3, which contained a small amount of raw materials in an appropriate ratio. This shows that skin absorption is good only when the formulation is stable and contains appropriate 2,3-butanediol and bis-ethoxydiglycolcyclohexane 1,4-dicarboxylate.
실험예 4: 피부 자극도 평가Experimental Example 4: Evaluation of skin irritation
피부 자극 평가를 위하여 한국 식품의약품안전청 기준 피부안전성 검사법에 따라 인체 첩포 시험을 실시하였다. 피시험자로 20-35세의 여성 20명을 선정하고 피시험자의 등 정중선을 피해 양쪽에 상기 실시예 및 비교예의 조성물을 각각 도포하고, 1시간 동안 방치해 놓은 후 하기 판정 기준에 따라서 피부 자극도를 평가하여 그 결과는 표 5에 나타내었다.To evaluate skin irritation, a human patch test was conducted according to the Korean Food and Drug Administration standard skin safety test method. Twenty women aged 20-35 were selected as test subjects, and the compositions of the examples and comparative examples were applied to both sides of the test subject's back, avoiding the midline. After leaving it for 1 hour, skin irritation was assessed according to the criteria below. was evaluated and the results are shown in Table 5.
상기 표 5에 나타낸 바와 같이, 실시예 1 내지 실시예 3 조성물은 피부 자극을 유발하지 않는 것으로 나타났으며, 특히 피부 흡수율 증진에 효과가 있는 2,3-부탄다이올, 비스-에톡시다이글라이콜사이클로헥산 1,4-다이카복실레이트, 에톡시다이글라이콜 3가지 원료를 과량 사용하였을 때(비교예 4) 피부 자극을 유발하였으나, 미량 혹은 적정량을 포함한 실시예 1 내지 실시예 3의 조성물에서는 피부 자극이 나타나지 않았다.As shown in Table 5, the compositions of Examples 1 to 3 were found not to cause skin irritation, and were particularly effective in improving skin absorption of 2,3-butanediol and bis-ethoxydigl. When the three raw materials lycolcyclohexane 1,4-dicarboxylate and ethoxydiglycol were used in excessive amounts (Comparative Example 4), skin irritation was caused, but in Examples 1 to 3 including trace or appropriate amounts The composition did not cause skin irritation.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220120143A KR20240041068A (en) | 2022-09-22 | 2022-09-22 | Cosmetic Composition With Enhancing Skin Absorption and Without Skin Irritation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220120143A KR20240041068A (en) | 2022-09-22 | 2022-09-22 | Cosmetic Composition With Enhancing Skin Absorption and Without Skin Irritation |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20240041068A true KR20240041068A (en) | 2024-03-29 |
Family
ID=90483817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220120143A KR20240041068A (en) | 2022-09-22 | 2022-09-22 | Cosmetic Composition With Enhancing Skin Absorption and Without Skin Irritation |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20240041068A (en) |
-
2022
- 2022-09-22 KR KR1020220120143A patent/KR20240041068A/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7324210B2 (en) | Topical preparations containing tofacitinib | |
EP1510213B1 (en) | Penetration enhancing and irritation reducing systems comprising testosterone | |
US7727537B2 (en) | Stabilized compositions for topical administration and methods of making same | |
KR101564434B1 (en) | A topical composition having enhanced skin penetration | |
DK1853303T3 (en) | STABILIZED COMPOSITIONS FOR TOPIC ADMINISTRATION AND PROCEDURES FOR PREPARING IT | |
US20110070213A1 (en) | Dermal compositions containing coenzyme q as the active ingredient | |
US20060088497A1 (en) | Topical skin care composition | |
AU2007269896A1 (en) | Ropinirole-containing pharmaceutical compositions in the form of a gel, uses thereof | |
WO2004060315A2 (en) | Stable topical drug delivery compositions | |
KR20190116693A (en) | Cosmetic composition for improving skin condition comprising human epidermal growth factor, peptides and functional materials | |
JP2024028934A (en) | External composition containing ascorbic acid and/or its salt | |
EP0535237A1 (en) | Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same | |
KR20240041068A (en) | Cosmetic Composition With Enhancing Skin Absorption and Without Skin Irritation | |
KR102022230B1 (en) | Structure of emulsions for enhancing the skin penetration and method of producing the same | |
JPS627A (en) | Skin external agent containing incorporated urea | |
WO2020067132A1 (en) | Topical composition containing ascorbic acid and/or salt thereof | |
JPH0551314A (en) | Skin cosmetics | |
KR20230147668A (en) | Hydrogel composition and use thereof in preventing and/or treating skin damage caused by radiation | |
KR102086316B1 (en) | Cosmetic composition having excellent percutaneous absorption property | |
WO2007086582A1 (en) | OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1α,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME | |
KR20200101709A (en) | Ice aqua-cream enhancing moisture and soothing effect on skin and its manufacturing method | |
KR102537299B1 (en) | Method for producing adhesive hydrogel for transdermal absorption and use thereof | |
KR100567373B1 (en) | Liquid Crystal Gel Whitening Cosmetic Composition_ | |
JPH07138279A (en) | Stabilization of peoniphlorin | |
JP5659407B2 (en) | Transdermal absorption-promoting skin external preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |